Aqr Capital Management LLC Adicet Bio, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.21 - $2.4 $136,869 - $271,476	113,115 Added 478.29%	136,765 $165,000
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $41,624 - $81,592	23,650 New	23,650 $55,000
Q3 2023 Nov 14, 2023	BUY	$1.37 - $3.4 $102,780 - $255,074	75,022 New	75,022 $102,000
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $26,425 - $72,807	3,423 Added 27.36%	15,933 $142,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $168,009 - $234,437	12,510 New	12,510 $178,000

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.